These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 24509818)

  • 1. Aberrant DNA methylation of microRNA genes in human breast cancer - a critical appraisal.
    Lehmann U
    Cell Tissue Res; 2014 Jun; 356(3):657-64. PubMed ID: 24509818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
    Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H
    J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel miRNA genes hypermethylated in breast cancer].
    Loginov VI; Burdennyy AM; Pronina IV; Khokonova VV; Kurevljov SV; Kazubskaya TP; Kushlinskii NE; Braga EA
    Mol Biol (Mosk); 2016; 50(5):797-802. PubMed ID: 27830681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epigenetic inactivation of microRNA genes in mammary carcinoma].
    Lehmann U; Hasemeier B; Römermann D; Müller M; Länger F; Kreipe H
    Verh Dtsch Ges Pathol; 2007; 91():214-20. PubMed ID: 18314617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8.
    Yu N; Huangyang P; Yang X; Han X; Yan R; Jia H; Shang Y; Sun L
    J Biol Chem; 2013 Jul; 288(27):19633-42. PubMed ID: 23720754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition.
    Carmona FJ; Davalos V; Vidal E; Gomez A; Heyn H; Hashimoto Y; Vizoso M; Martinez-Cardus A; Sayols S; Ferreira HJ; Sánchez-Mut JV; Morán S; Margelí M; Castella E; Berdasco M; Stefansson OA; Eyfjord JE; Gonzalez-Suarez E; Dopazo J; Orozco M; Gut IG; Esteller M
    Cancer Res; 2014 Oct; 74(19):5608-19. PubMed ID: 25106427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of breast cancer DNA methylation markers optimized for fine-needle aspiration samples.
    Bu D; Lewis CM; Sarode V; Chen M; Ma X; Lazorwitz AM; Rao R; Leitch M; Moldrem A; Andrews V; Gazdar A; Euhus D
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2212-21. PubMed ID: 24089458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
    Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
    J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles: their role in cancer biology and epithelial-mesenchymal transition.
    Gopal SK; Greening DW; Rai A; Chen M; Xu R; Shafiq A; Mathias RA; Zhu HJ; Simpson RJ
    Biochem J; 2017 Jan; 474(1):21-45. PubMed ID: 28008089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics in esophageal cancers.
    Ahrens TD; Werner M; Lassmann S
    Cell Tissue Res; 2014 Jun; 356(3):643-55. PubMed ID: 24816987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
    Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
    Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
    Nass SJ; Herman JG; Gabrielson E; Iversen PW; Parl FF; Davidson NE; Graff JR
    Cancer Res; 2000 Aug; 60(16):4346-8. PubMed ID: 10969774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
    Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
    Zmetakova I; Danihel L; Smolkova B; Mego M; Kajabova V; Krivulcik T; Rusnak I; Rychly B; Danis D; Repiska V; Blasko P; Karaba M; Benca J; Pechan J; Fridrichova I
    Neoplasma; 2013; 60(6):635-46. PubMed ID: 23906298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of free tumor-related DNA in the serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Deng GR
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites.
    Sadikovic B; Haines TR; Butcher DT; Rodenhiser DI
    Breast Cancer Res; 2004; 6(4):R329-37. PubMed ID: 15217500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced BMP6 expression by DNA methylation contributes to EMT and drug resistance in breast cancer cells.
    Liu G; Liu YJ; Lian WJ; Zhao ZW; Yi T; Zhou HY
    Oncol Rep; 2014 Aug; 32(2):581-8. PubMed ID: 24890613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.